glutathion stransferase Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications Glutathione transferases: substrates, inihibitors and

Therefore both B12 and folate deficiency can result in anaemia and intestinal atrophy

As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes

These are perfect for your record keeping

More details are explained on the GlyNAC benefits page